Erratum: Early administration of propofol protects against endotoxin-induced acute lung injury in rats by inhibiting the TGF-β1-Smad2 dependent pathway (Inflammation Research DOI: 10.1007/s00011-009-0110-y);Early administration of propofol protects against endotoxin-induced acute lung injury in rats by inhibiting the TGF-β1-Smad2 dependent pathway

Inflammation Research

Volumn 59, Issue 7, 2010, Pages 491-500

  Gao, Ju ^a   Zhao, Wei Xian ^a   Xue, Fu Shan ^b   Zhou, Luo Jing ^c   Xu, Shao Qun ^a   Ding, Ning ^d  

^a GUANGDONG PROVINCIAL HOSPITAL OF CHINESE MEDICINE   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

^c GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

^d GUANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

Author keywords

Lipopolysaccharide; Lung injury; Propofol; Transforming growth factor 1

Indexed keywords

ENDOTOXIN; LIPOPOLYSACCHARIDE; MYELOPEROXIDASE; PROPOFOL; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; INTRAVENOUS ANESTHETIC AGENT; MADH2 PROTEIN, RAT; PEROXIDASE;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIAL GAS; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DRUG EFFECT; HEMODYNAMICS; HISTOPATHOLOGY; LUNG BLOOD VESSEL; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SCORING SYSTEM; SURVIVAL RATE; ANIMAL; DRUG EFFECTS; GENETICS; HUMAN; LUNG; METABOLISM; PATHOLOGY; PHYSIOLOGY; RANDOMIZATION; SIGNAL TRANSDUCTION; WISTAR RAT;

ACUTE LUNG INJURY; ANESTHETICS, INTRAVENOUS; ANIMALS; HEMODYNAMICS; HUMANS; LIPOPOLYSACCHARIDES; LUNG; MALE; PEROXIDASE; PROPOFOL; RANDOM ALLOCATION; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SURVIVAL RATE; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77955716472     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-010-0218-0     Document Type: Erratum

References (28)

1. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000;342:1334-9.
2. Pugin J, Verghese G, Widmer MC, Matthay MA. The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome. Crit Care Med. 1999;27:304-12.
3. Wesselkamper SC, Case LM, Henning LN, Borchers MT, Tichelaar JW, Mason JM, et al. Gene expression changes during the development of acute lung injury: role of transforming growth factor-b. Am J Respir Crit Care Med. 2005;172:1399-411.
4. Fahy RJ, Lichtenberger F, McKeegan CB, Nuovo GJ, Marsh CB, Wewers MD. The acute respiratory distress syndrome: a role for transforming growth factor-β1. Am J Respir Cell Mol Biol. 2003;28:499-503.
5. Kolb M, Margetts PJ, Anthony DC, Pitossi F, Gauldie J. Transient expression of IL-1β induces acute lung injury and chronic repair leading to pulmonary fibrosis. J Clin Invest. 2001;107:1529-36.
6. Birukova AA, Birukov KG, Adyshev D, Usatyuk P, Natarajan V, Garcia JG, et al. Involvement of microtubules and Rho pathway in TGF-β-induced lung vascular barrier dysfunction. J Cell Physiol. 2005;204:934-7.
7. Clements RT, Minnear FL, Singer HA, Keller RS, Vincent PA. RhoA and Rhokinase dependent and independent signals mediate TGF-β-induced pulmonary endothelial cytoskeletal reorganization and permeability. Am J Physiol Lung Cell Mol Physiol. 2005;288:L294-306.
8. Shenkar R, Coulson WF, Abraham E. Anti- TGF-b1 monoclonal antibodies prevent lung injury in hemorrhaged mice. Am J Respir Cell Mol Biol. 1994;11:351-7.
9. Marik PE, Zaloga GP. Therapeutic sedation: has its time come? Crit Care Med. 2002;30:949-52.
10. Young C, Knudsen N, Andrew H. Sedation in the intensive care unit. Crit Care Med. 2000;28:854-66.
11. Kwak SH, Choi JI, Park JT. Effects of propofol on endotoxininduced acute lung injury in rabbit. J Korean Med Sci. 2004;19:55-61.
12. Chen RM, Chen TG, Chen TL, Lin LL, Chang CC, Chang HC, et al. Anti-inflammatory and antioxidative effects of propofol on lipopolysaccharide- activated macrophages. Ann NY Acad Sci. 2005;1042:262-71.
13. Taniguchi T, Kanakura H, Yamamoto K. Effects of posttreatment with propofol on mortality and cytokine responses to endotoxininduced shock in rats. Crit Care Med. 2002;30:904-7.
14. Gao J, Zhao WX, Zhou LJ, Zeng BX, Yao SL, Liu D, et al. Protective effects of propofol on lipopolysaccharide-activated endothelial cell barrier dysfunction. Inflamm Res. 2006; 55:385-92.
15. Takao Y, Mikawa K, Nishina K, Obara H. Attenuation of acute lung injury with propofol in endotoxemia. Anesth Analg. 2005;100:810-6.
16. Groeneveld ABJ. Vascular pharmacology of acute lung injury and acute respiratory distress syndrome. Vasc Pharm. 2003;39:247-56.
17. Ware LB, Matthay MB. The acute respiratory distress syndrome. N Engl J Med. 2000;342:1334-49.
18. Pittet JF, Griffiths MJ, Geiser T, Kaminski N, Dalton SL, Huang X, et al. TGF-β is a critical mediator of acute lung injury. J Clin Invest. 2001;107:1537-44.
19. Derynck R, Zhang Y, Feng XH. Smads: transcriptional activators of TGF-β responses. Cell. 1998;95:737-40.
20. Lu Q, Harrington EO, Jackson H, Morin N, Shannon C, Rounds S. Transforming growth factor-beta1-induced endothelial barrier dysfunction involves SMAD2-dependent p38 activation and subsequent RhoA activation. J Appl Physiol. 2006;101:375-84.
21. Shen X, Li J, Hu PP, Waddell D, Zhang J, Wang XF. The activity of guanine exchange factor NET1 is essential for transforming growth factor-beta-mediated stress fiber formation. J Biol Chem. 2001;276:15362-8.
22. Green TR, Bennett SR, Nelson VM. Specificity and properties of propofol as an antioxidant free radical scavenger. Toxicol Appl Pharmacol. 1994;129:163-9.
23. Heller A, Heller S, Blecken S, Urbaschek R, Koch T. Effects of intravenous anesthetics on bacterial elimination in human blood in vitro. Acta Anaesthesiol Scand. 1998;425:518-26.
24. Taniguchi T, Yamamoto K, Ohmoto N, Ohta K, Kobayashi T. Effects of propofol on hemodynamic and inflammatory responses to endotoxemia in rats. Crit Care Med. 2000;28:1101-6.
25. Fan J, Marshall JC, Jimenez M, Shek PN, Zagorski J, Rotstein OD. Hemorrhagic shock primes for increased expression of cytokine-induced neutrophil chemoattractant in the lung: role in pulmonary inflammation following lipopolysaccharide. J Immunol. 1998;161:440-7.
26. Gordon BR, Parker TS, Levine DM, Saal SD, Wang JC, Sloan BJ, et al. Low lipid concentrations in critical illness: implications for preventing and treating endotoxemia. Crit Care Med. 1996;24:584-9.
27. Hubsch AP, Powell FS, Lerch PG, Doran JE. A reconstituted, apolipoprotein A-I containing lipoprotein reduces tumor necrosis factor release and attenuates shock in endotoxemic rabbits. Circ Shock. 1993;40:14-23.
28. Baker MT, Naguib M. Propofol: the challenges of formulation. Anesthesiology. 2005;103:860-76.